The collective discussions show strong support and fascination with the study's novel approach, such as references to 'decoding evolutionary dynamics' and phrases like 'significant breakthroughs,' reflecting excitement about how plasma genome sequencing could improve understanding and management of prostate cancer over time.
AgreementStrong agreement
All discussions highlight the significance of the research, emphasizing its innovative approach and positive outlook towards the findings.
InterestHigh interest
Comments demonstrate high engagement with the topic, referencing specific methods like plasma DNA sequencing and its implications for prostate cancer treatment.
EngagementHigh engagement
Postings involve detailed mentions of the study’s methodology, such as tracking tumor evolution and genetic patterns, indicating deep involvement.
ImpactHigh impact
The discussions frequently describe the research as transformative or groundbreaking, suggesting high perceived impact on cancer diagnostics and treatment strategies.
Abstract in brief
The study develops a new method using plasma DNA sequencing to track genetic changes in prostate cancer patients, especially since collecting tissue samples over time is challenging.
Analysis of plasma DNA from 233 patients revealed links between certain genetic patterns, like aneuploidy, and worse survival outcomes, and confirmed that plasma DNA accurately reflects tumor genetic alterations.
Longitudinal sequencing of serial plasma samples showed tumor evolution over time, with some minor clones expanding in response to therapy and gaining mutations that could lead to treatment resistance, helping to understand how prostate cancer adapts.
New paper from our group out in @GenomeBiology on decoding evolutionary dynamics of prostate cancer in response to therapy https://t.co/FxUuAvNIDY thanks to hard work from @Naveen_Ramesh1
Study of prostate cancer response to therapy from @Naveen_Ramesh1, @azursaa, @nicholas_navin and co. They sequence plasma DNA, and find changes that match changes in metastases, and which respond after chemotherapy https://t.co/VndMJdBhoX https://t.co/lEqCz7qyA9
Decoding the evolutionary response to
prostate cancer therapy by plasma genome
sequencing
@MDAndersonNews @OPENoncology @OncoAlert @GenomeBiology #CáncerdePróstata
https://t.co/SwhVAcLubo https://t.co/RYjzvmpEr1
Explore cancer as an accelerated evolution within the human body, examining how mutation, natural selection, and adaptation inform tumor behavior and treatment strategies based on Darwinian medicine.
Decoding the evolutionary response to
prostate cancer therapy by plasma genome
sequencing
@MDAndersonNews @OPENoncology @OncoAlert @GenomeBiology #CáncerdePróstata
https://t.co/SwhVAcLubo https://t.co/RYjzvmpEr1
New paper from our group out in @GenomeBiology on decoding evolutionary dynamics of prostate cancer in response to therapy https://t.co/FxUuAvNIDY thanks to hard work from @Naveen_Ramesh1
Study of prostate cancer response to therapy from @Naveen_Ramesh1, @azursaa, @nicholas_navin and co. They sequence plasma DNA, and find changes that match changes in metastases, and which respond after chemotherapy https://t.co/VndMJdBhoX https://t.co/lEqCz7qyA9